Abstract
In spite of major advances in the care of critically ill patients, septic shock remains a commonly fatal condition, with a mortality rate averaging 50% [1], Recent progress in the understanding of the pathophysiology of septic shock has prompted an intense search for new therapeutic modalities. In particular, the recognition that an enhanced production of the vasodilator nitric oxide (NO) from an inducible isoform of NO synthase (iNOS) plays a major role in sepsis-induced hypotension, has suggested that the pharmacological inhibition of iNOS might be of great therapeutic value in this setting [2]. In this article, we will review the current state of knowledge regarding the inhibition of NO production in experimental septic shock, by focusing on the most recent data obtained with the newly developed selective inhibitors of iNOS.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bone RC (1991) The pathogenesis of sepsis. Ann Intern Med 115: 457–469
Szabo C (1995) Alterations in nitric oxide production in various forms of circulatory shock. New Horizons 3: 2–32
Thiemermann C (1997) Nitric oxide and septic shock. Gen Pharmacol 29: 159–166
Kilbourn RG, Traber DL, Szabo C (1997) Nitric oxide and shock. Disease-a-Month 43: 281–348
Cobb JP, Danner RL (1996) Nitric oxide and septic shock. JAMA 275: 1192–1196
Kilbourn RG, Szabo C, Traber DL (1997) Beneficial versus detrimental effects of nitric oxide synthase inhibitors in circulatory shock: lessons learned from experimental and clinical studies. Shock 7: 235–246
MacMicking JD, Nathan C, Horn G, et al (1995) Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 81: 641–650
Salzman AL (1995) Nitric oxide and the gut. New Horizons 3: 33–45
Szabo C (1996) DNA strand breakage and activation of poly-ADP ribosyltransferase: a cytotoxic pathway triggered by peroxynitrite. Free Rad Biol Med 21: 855–869
Kilbourn RG, Gross SS, Jubran A, et al (1990) NG-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide. Proc Natl Acad Sci USA 87: 3629–3632
Kilbourn RG, Jubran A, Gross SS, et al (1990) Reversal of endotoxin-mediated shock by NG-methyl-L-arginine, an inhibitor of nitric oxide synthesis. Biochem Biophys Res Commun 172: 1132–1138
Thiemermann C, Vane J (1990) Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharides in the rat in vivo. Eur J Pharmacol 182: 591–595
Magder S, Vanelli G (1994) Venous circuit adaptations during high cardiac output sepsis in pigs. Am J Respir Crit Care Med 149: A654 (Abst)
Avontuur JAM, Bruining H, Ince C (1995) Inhibition of nitric oxide synthesis causes myocardial ischemia in endotoxemic rats. Circ Res 76: 418–425
Cobb JP, Natanson C, Hoffman WD, et al (1992) N-Amino-L-Arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxin. J Exp Med 176: 1175–1182
Robertson FM, Offner PJ, Ciceri DP, Bechker WK, Pruitt BA (1994) Detrimental hemodynamic effects of nitric oxide synthase inhibition in septic shock. Arch Surg 129: 149–156
Spain DA, Wilson MA, Garison RN (1994) Nitric oxide synthase inhibition exacerbates sepsis-induced renal hypoperfusion. Surgery 116: 322–331
Shultz P, Raij L (1992) Endogenously synthesized nitric oxide prevents endotoxin-induced glomerular thrombosis. J Clin Invest 90: 1718–1725
Statman R, Cheng W, Cunningham JN, et al (1994) Nitric oxide inhibition in the treatment of the sepsis syndrome is detrimental to tissue oxygenation. J Surg Res 57: 93–98
Harbrecht BG, Billiar TR, Stadler J, et al (1992) Nitric oxide synthesis serves to reduce hepatic damage during acute murine endotoxemia. Crit Care Med 20: 1568–1574
Evans T, Carpenter A, Silva A, Cohen J (1994) Inhibition of nitric oxide synthase in experimental Gram-negative sepsis. J Infect Dis 169: 343–349
Liaudet L, Rosselet A, Schaller MD, Markert M, Perret C, Feihl F (1998) Nonselective versus selective inhibition of inducible nitric oxide synthase in experimental endotoxic shock. J Infect Dis (In press)
Minnard EA, Shou J, Naama H, Cech A, Gallagher H, Daly JM (1994) Inhibition of nitric oxide synthesis is detrimental during endotoxemia. Arch Surg 129: 142–148
Boughton-Smith NK, Hutcheson IR, Deakin AM, Whittle BJR, Moncada S (1990) Protective effect of S-nitroso-N-acetyl-penicillamine in endotoxin-induced acute intestinal damage in the rat. Eur J Pharmacol 191: 485–488
Wright CE, Rees DD, Moncada S (1992) Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc Res 26: 48–57
Traber DL (1996) Presence and absence of nitric oxide synthase in sepsis. Crit Care Med 24: 1102–1103
Liaudet L, Feihl F, Rosselet A, Markert M, Perret C (1996) Beneficial effects of L-canavanine, a selective inhibitor of inducible nitric oxide synthase, during rodent endotoxemia. Clin Sci 90: 369–377
Moore WM, Webber RK, Jerome GM, Tjoeng FS, Misko TP, Currie MG (1994) L-N6-(1- Iminoethyl)lysine: a selective inhibitor of inducible nitric oxide synthase. J Med Chem 37: 3886–3888
Southan GJ, Szabo C, O’Connor MP, Salzman AL, Thiemermann C (1995) Amidines are potent inhibitors of nitric oxide synthases: preferential inhibition of the inducible isoform. Eur J Pharmacol 291: 311–318
Misko TP, Moore WM, Kasten T, et al (1993) Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur J Pharmacol 233: 119–125
Southan GJ, Szabo C, Thiemermann C (1995) Isothioureas: potent inhibitors of nitric oxide synthases with variable isoform selectivity. Br J Pharmacol 114: 510–516
Southan GJ, Zingarelli B, O’Connor M, Salzman A, Szabo C (1996) Spontaneous rearrangement of aminoalkylisothioureas into mercaptoalkylguanidines, a novel class of nitric oxide synthase inhibitors with selectivity towards the inducible isoform. Br J Pharmacol 117: 619–632
Southan GJ, Szabo C (1996) Selective pharmacological inhibition of distinct nitric oxide synthase isoforms. Biochem Pharmacol 51: 383–394
Fink MP, Heard SO (1990) Laboratory models of sepsis and septic shock. J Surg Res 49: 186–196
Liaudet L, Fishman D, Markert M, Perret C, Feihl F (1997) L-canavanine improves organ function and tissue adenosine triphosphate levels in rodent endotoxemia. Am J Respir Crit Care Med 155: 1643–1648
Rosselet A, Feihl F, Markert M, Perret C, Liaudet L (1998) Selective iNOS inhibition is superior to norepinephrine in the treatment of rat endotoxic shock. Am J Respir Crit Care Med (In press)
Kengatharan KM, De Kimpe SJ, Thiemermann C (1996) Role of nitric oxide in the circulatory failure and organ injury in a rodent model of Gram-positive shock. Br J Pharmacol 119: 1411–1421
Wu CC, Chen SJ, Szabo C, Thiemermann C, Vane JR (1995) Aminoguanidine attenuates the delayed circulatory failure and improves survival in rodent models of endotoxic shock. Br J Pharmacol 114: 1666–1672
Szabo C, Bryk R, Zingarelli B, et al (1996) Pharmacological characterization of guanidinoethyl- disulphide (GED), a novel inhibitor of nitric oxide synthase with selectivity towards the inducible isoform. Br J Pharmacol 118: 1659–1668
Thiemermann C, Ruetten H, Wu CC, Vane JR (1995) The multiple organ dysfunction syndrome caused by endotoxin in the rat: attenuation of liver dysfunction by inhibitors of nitric oxide synthase. Br J Pharmacol 116: 2845–2851
Fatehihassanabad Z, Burns H, Aughey E, et al (1996) Effects of L-canavanine, an inhibitor of inducible nitric oxide synthase, on endotoxin-mediated shock in rats. Shock 6: 194–200
Cai M, Sakamoto A, Ogawa R (1996) Inhibition of nitric oxide formation with L-canavanine attenuates endotoxin-induced vascular hyporeactivity in the rat. Eur J Pharmacol 295: 215–220
Teale DM, Atkinson AM (1994) L-canavanine restores blood pressure in a rat model of endotoxic shock. Eur J Pharmacol 271: 87–92
Ruetten H, Southan GJ, Abate A, Thiemermann C (1996) Attenuation of endotoxin-induced multiple organ dysfunction by 1-amino-2-hydroxy-guanidine, a potent inhibitor of inducible nitric oxide synthase. Br J Pharmacol 118: 261–270
Fishman D, Liaudet L, Lazor R, Feihl F, Perret C (1997) L-canavanine, an inhibitor of inducible nitric oxide synthase, improves venous return in endotoxemic rats. Crit Care Med 25: 469–475
Wu CC, Ruetten H, Thiemermann C (1996) Comparison of the effects of aminoguanidine and N-omega-nitro-L-arginine methyl ester on the multiple organ dysfunction caused by endotoxaemia in the rat. Eur J Pharmacol 300: 99–104
Arkovitz MS, Wispe JR, Garcia VF, Szabo C (1996) Selective inhibition of the inducible isoform of nitric oxide synthase prevent pulmonary transvascular flux during acute endotoxemia. J Ped Surg 31: 1009–1015
Sorrells DL, Friend C, Koltuksuz U, et al (1996) Inhibition of nitric oxide with aminoguanidine reduces bacterial translocation after endotoxin challenge in vivo. Arch Surg 131: 1155–1163
Hock CE, Yin K, Yue G, Wong PYK (1997) Effects of inhibition of nitric oxide synthase by aminoguanidine in acute endotoxemia. Am J Physiol 272: H843–H850
Yen MH, Liu YC, Hong HJ, Sheu JR, Wu CC (1997) Role of nitric oxide in lipopolysaccharide-induced mortality from spontaneously hypertensive rats. Life Sci 60: 1223–1230
Gardiner SM, Kemp PA, March JE, Bennett T (1996) Influence of aminoguanidine and the endothelin antagonist, SB 209670, on the regional haemodynamic effects of endotoxaemia in conscious rats. Br J Pharmacol 118: 1822–1828
Huang TP, Nishida T, Kamiike W, et al (1997) Role of nitric oxide in oxygen transport in rat liver sinusoids during endotoxemia. Hepatology 26: 336–342
Szabo C, Southan GJ, Thiemermann C (1994) Beneficial effects and improved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase. Proc Natl Acad Sci USA 91: 12472–12476
Aranow JS, Zhuang J, Wang H, Larkin V, Smith M, Fink MP (1996) A selective inhibitor of inducible nitric oxide synthase prolongs survival in a rat model of bacterial peritonitis: comparison with two nonselective strategies. Shock 5: 116–121
Schwartz D, Mendonca M, Schwartz I, et al (1997) Inhibition of constitutive nitric oxide synthase (NOS) by nitric oxide generated by inducible NOS after lipopolysaccharide administration provokes renal dysfunction in rats. J Clin Invest 100: 439–448
Nava E, Palmer RMJ, Moncada S (1991) Inhibition of nitric oxide synthesis in septic shock: how much is beneficial? Lancet 338: 1555–1557
Meyer J, Traber LD, Nelson S, et al (1992) Reversal of hyperdynamic response to continuous endotoxin administration by inhibition of NO synthesis. J Appl Physiol 73: 324–328
Meyer J, Lentz CW, Stothert JC, Traber LD, Herndon DN, Traber DL (1994) Effects of nitric oxide synthesis inhibition in hyperdynamic endotoxemia. Crit Care Med 22: 306–312
Rengasamy A, Johns RA (1993) Regulation of nitric oxide synthase by nitric oxide. Mol Pharmacol 44: 124–128
Filippov G, Bloch DB, Bloch KD (1997) Nitric oxide decreases stability of mRNAs encoding soluble guanylate cyclase subunits in rat pulmonary artery smooth muscle cells. J Clin Invest 100: 942–948
Salzman AL, Menconi MJ, Unno N, et al (1995) Nitric oxide dilates tight junctions and deletes ATP in cultured Caco-2BBe intestinal epithelial monolayers. Am J Physiol 268: G361–G373
Teale DM, Atkinson M (1992) Inhibition of nitric oxide synthesis improves survival in a murine peritonitis model of sepsis that is not cured by antibiotics alone. J Antimicrob Chemother 30: 839–842
Wei XQ, Charles IG, Smith A, et al (1995) Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375: 408–411
Laubach VE, Shesely EG, Smithies O, Sherman PA (1995) Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc Natl Acad Sci USA 92: 10688–10692
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Liaudet, L., Schaller, M.D., Feihl, F. (1998). Selective Pharmacological Inhibition of Inducible Nitric Oxide Synthase in Experimental Septic Shock. In: Vincent, JL. (eds) Yearbook of Intensive Care and Emergency Medicine 1998. Yearbook of Intensive Care and Emergency Medicine, vol 1998. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-72038-3_15
Download citation
DOI: https://doi.org/10.1007/978-3-642-72038-3_15
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-63798-1
Online ISBN: 978-3-642-72038-3
eBook Packages: Springer Book Archive